In the study of over 200 patients, 90.1% of those who received TC-325 had their bleeding controlled within 30 days, as compared to 81.4% of those who received standard treatment, meeting criteria for ...

Marks Baxter’s entry into the attractive global hemostatic powder segment, broadening its portfolio offering to include a wider range of active and passive solutions Addressing intraoperative bleeding ...

SEOUL, South Korea, May 29, 2025 /PRNewswire/ -- Nextbiomedical announced today that its novel hemostatic powder, Nexpowder™, has been published in GUT (Impact Factor: 23), one of the world's most ...

Marks first passive hemostat for Baxter in the U.S. market, broadening portfolio offering to include a full range of active and passive hemostatic products PERCLOT further enhances clinicians’ ability ...

Add Yahoo as a preferred source to see more of our stories on Google. Their breakthrough AGCL powder forms an instant hydrogel barrier the moment it touches blood, sealing wounds that would normally ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--EndoClot Plus, Inc., a privately held medical device company founded by surgeons and biomaterial scientists announces the CE approval of EndoClot ® Adhesive ...

It sounds like sci-fi, but it’s real. Scientists have discovered a revolutionary way to stop uncontrollable bleeding in just one second. See how it works.

SOMERVILLE, N.J., June 6, 2017 /PRNewswire/ -- Uncontrolled bleeding during surgery can adversely affect patient outcomes, hospital costs and resources. 1-9 Primary methods of hemostasis alone may be ...

On modern battlefields and city streets alike, the difference between life and death after a major injury is often measured ...

COLLEGE PARK, Md., Sept. 25, 2024 /PRNewswire/ -- Medcura, Inc., a leader in innovative hemostasis solutions that deploy patented biopolymer technologies to control surgical bleeding, is pleased to ...